AUPH Aurinia Pharmaceuticals Inc Gross Profit Rate

Official company branding of Aurinia Pharmaceuticals Inc (AUPH)

Planned gross margin helps assess the risks of Aurinia Pharmaceuticals (AUPH), whose revenues are heavily dependent on a single drug and regulatory restrictions. Competition with corporate behemoths is slowing brand expansion, however, 90.60 shows the current volume of this performance metric. High profitability and the exclusivity of renal pathology therapies provide the company with excellent scaling potential through an advanced distribution network.

AUPH Aurinia Pharmaceuticals Inc Gross Profitability (07/04/2022 - 11/20/2026)

Financial and market metric breakdowns for Aurinia Corp (AUPH)

- market value and analyst target forecast:
Summary company analysis:Aurinia Pharmaceuticals Inc (AUPH)
Mass-produced product of Aurinia Pharma

Gross margin is calculated as the ratio of the difference between revenue and cost of goods sold to total sales, measuring the efficiency of direct production. The current value of 90.60 reflects the ability of Aurinia Pharmaceuticals (AUPH) to maintain profitability amid dependence on a single drug and patent risks, making the gross profit margin history a key indicator of the business's resilience to competition.

Main competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|BCRX - Return on Sales by Gross Profit|VERA (Vera Corp) - Gross Margin|Dianthus Pharma (DNTH) - Return on Sales by Gross Profit|Gross Profitability Pharvaris Pharma (PHVS)|Gross Margin AbCellera Corp (ABCL)|Gross Margin TRML (Tourmaline Bio Inc)|Return on Sales by Gross Profit precigen.com (PGEN)|PHAR - Gross Profitability|Gross Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Gross Profit|Zenas Corp (ZBIO) - Gross Margin|Return on Gross Profit IMNM|GOSS: Gross Profit Rate|Gross Profitability KalVista Pharma (KALV)|SEPN - Gross Profit Margin|Gross Margin PVLA (pieris.com)|Gross Margin Savara Pharma SVRA|RIGL: Return on Gross Profit|ANAB - Gross Margin|ATXS: Gross Margin|ENGN - Return on Sales by Gross Profit|Return on Gross Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Gross Profit Ratio|Gross Margin ACRS|Return on Gross Profit kyvernatx.com KYTX|Gross Margin TLSA (Tiziana Life Sciences, Ltd.)|Gross Margin Cabaletta Bio CABA|VTYX: Return on Gross Profit|Theratechnologies Inc. (THTX) - Return on Gross Profit|AVTX: Gross Margin|ELDN - Return on Sales by Gross Profit|AGEN (Agenus, Inc) - Gross Margin|Gross Margin Climb Bio, Inc.|Gross Profitability Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Gross Profit Rate|Gross Margin ADAG (Adagene Inc)|IMA - Return on Gross Profit|STTK - Gross Profitability|EQ (equilliumbio.com) - Gross Return on Sales|CNTB: Gross Margin|Immunic Inc (IMUX) - Gross Margin|ATRA (Atara Biotherapeutics Inc) - Gross Margin|Gross Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Gross Profit Rate|Adicet Bio, Inc. - Gross Return on Sales|Celularity Inc - Return on Gross Profit|Gross Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability